Eucure (Beijing) Biopharma Co.
Latest round
- Series B
Last raised
- Mar 2018
Total raised
- $38M
Investors
- 4
About Eucure (Beijing) Biopharma Co.
, Ltd. is a biotechnology company that develops therapeutic antibodies for cancer treatment.
Who invested in Eucure (Beijing) Biopharma Co.
4 investors across 3 rounds
See all investors in Eucure (Beijing) Biopharma Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Eucure (Beijing) Biopharma Co.
Who invested in Eucure (Beijing) Biopharma Co.?
Eucure (Beijing) Biopharma Co. has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Eucure (Beijing) Biopharma Co. raised?
Eucure (Beijing) Biopharma Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Eucure (Beijing) Biopharma Co. last raise money?
Eucure (Beijing) Biopharma Co.'s most recent round on record is a Series B, in Mar 2018.
What does Eucure (Beijing) Biopharma Co. do?
Eucure (Beijing) Biopharma Co. is a biotechnology company.
Where is Eucure (Beijing) Biopharma Co. headquartered?
Eucure (Beijing) Biopharma Co. is headquartered in Beijing, China.
Which VCs invest in companies like Eucure (Beijing) Biopharma Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Eucure (Beijing) Biopharma Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Eucure (Beijing) Biopharma Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.